In the late 1990s/mid 2000s, Forest Laboratories illegally promoted its antidepressant Celexa (citalopram) for use in children and adolescents, even though it was only approved for adults.
The company publicized positive study results while deliberately hiding negative results showing the drug was ineffective in this age group.
Forest pleaded guilty to this and other false claims and paid more than $313 million in fines and settlements.
Attribution: — United States Department of Justice, 15 September 2010